Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Interest Expenses (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Interest Expenses for 16 consecutive years, with $4.4 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 528.57% to $4.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.5 million through Dec 2025, up 275.0% year-over-year, with the annual reading at $10.5 million for FY2025, 275.0% up from the prior year.
  • Interest Expenses for Q4 2025 was $4.4 million at Myriad Genetics, up from $3.8 million in the prior quarter.
  • The five-year high for Interest Expenses was $4.4 million in Q4 2025, with the low at $500000.0 in Q4 2021.
  • Average Interest Expenses over 5 years is $1.3 million, with a median of $850000.0 recorded in 2022.
  • The sharpest move saw Interest Expenses plummeted 91.38% in 2021, then surged 528.57% in 2025.
  • Over 5 years, Interest Expenses stood at $500000.0 in 2021, then skyrocketed by 80.0% to $900000.0 in 2022, then changed by 0.0% to $900000.0 in 2023, then fell by 22.22% to $700000.0 in 2024, then soared by 528.57% to $4.4 million in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $4.4 million, $3.8 million, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.